000710 贝瑞基因
2021/06 - 中期2020/122019/122018/122017/12

盈利能力分析
净资产收益率 ROE (%)1.2828.93218.46115.58717.989
总资产报酬率 ROA (%)0.9506.67414.89013.45715.365
投入资产回报率 ROIC (%)1.0747.73817.34115.07817.216

边际利润分析
销售毛利率 (%)49.51752.62561.12858.23861.128
营业利润率 (%)5.97015.91627.83021.18823.489
息税前利润/营业总收入 (%)6.99516.87727.50822.11323.976
净利润/营业总收入 (%)4.29913.35323.93218.04220.872

收益指标分析
经营活动净收益/利润总额(%)166.65292.81299.389110.46195.711
价值变动净收益/利润总额(%)-58.76516.8733.391-10.244-0.427
营业外收支净额/利润总额(%)1.0930.075-1.0141.8933.212

偿债能力分析
流动比率 (X)3.6713.6094.1196.0224.631
速动比率 (X)3.2363.2853.1815.1094.179
资产负债率 (%)24.46925.32523.52110.82113.615
带息债务/全部投入资本 (%)15.09714.9889.455-0.5416.552
股东权益/带息债务 (%)553.674560.463946.505-18,487.7451,419.026
股东权益/负债合计 (%)304.484290.734322.568807.652624.783
利息保障倍数 (X)7.29617.774-641.98542.838-82.052

营运能力分析
应收账款周转天数 (天)280.413223.209165.417145.084123.678
存货周转天数 (天)103.532148.519179.65393.77174.883